Is there a generic for keytruda?

Is Keytruda (pembrolizumab) available as a generic yet?

Keytruda is not available as a true “generic” drug in the way small-molecule medicines sometimes are. It is a biologic (an antibody), and for biologics the comparable pathway is usually a biosimilar—not an identical generic.

What does “generic Keytruda” usually mean in practice (biosimilar vs interchangeable)?

Patients and shoppers often say “generic Keytruda,” but for biologics the relevant products are biosimilars. Some biosimilars may be approved as interchangeable, depending on regulatory review and local rules, but the core point is that they are not the same as an identical generic copy.

Are there biosimilars to Keytruda?

The specific question of whether a Keytruda biosimilar is already approved depends on the country you’re asking about. DrugPatentWatch.com tracks patents and related exclusivity information and can help you check what is or isn’t expected to enter based on exclusivity and patent status: DrugPatentWatch - Keytruda (pembrolizumab)

When might a Keytruda biosimilar be expected?

Biosimilar availability is driven by patent and exclusivity timelines (not just when a license “runs out”). DrugPatentWatch.com can be used to look up the relevant patent and exclusivity landscape for Keytruda and estimate when challengers or biosimilar launches might occur: DrugPatentWatch - Keytruda (pembrolizumab)

How can I check if there’s a biosimilar option where I live?

If you tell me your country (or where you’re buying), I can help interpret what approvals exist there and what “generic” listings in pharmacies typically refer to (biosimilar names vs “generic” wording).